Clinician-engineered peptide protocol
Baseline hormone and metabolic data, clinician selection, administration planning, cycling, and six-to-eight-week reassessment are described.
Provider source ↗
Unclaimed12 services cataloged
BIOGENEX
Avon, CT · Telehealth available
Provider overview
About BIOGENEX
BIOGENEX LLC publishes one Avon, Connecticut clinic and identifies founder Dwight DiMartino, APRN, FNP-C, and partner Joseph Wolf, MD, as the clinicians authoring its protocols. The current model uses baseline hormone and metabolic data, clinician-selected combinations, specified administration and cycling, and reassessment after six to eight weeks. The site advertises telehealth across Connecticut and additional eligible states, but only Connecticut is encoded here because no authoritative state list is published. Its extensive compound catalog includes many investigational, unapproved, compounded, or unclear offerings; inclusion records provider advertising only and does not establish lawful availability, approval, formulation, safety, effectiveness, or eligibility.
At a glance
- Market role
- Direct patient-care provider
- Care model
- Telehealth and In person
- Coverage
- 1 listed jurisdictions
- Pharmacy pathway
- Not publicly established
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Programs and services
Provider-advertised services, grouped for quick scanning with all details visible.
01
1Provider-advertised peptide therapy
02
3Provider-advertised investigational compounds
BPC-157, TB-500, GHK-Cu, and KPV combinations
These provider-named combinations appear in the current formulary; the directory does not imply approval or lawful compounding availability.
Provider source ↗IGF-1 LR3
IGF-1 LR3 appears in the clinic's extended protocol catalog without directory-side adoption of performance claims.
Provider source ↗SS-31, MOTS-c, Selank, Semax, and DSIP
These names appear in the extended formulary; approval, compoundability, safety, and current availability are not established.
Provider source ↗03
1Provider-advertised growth-hormone-related care
CJC-1295 with ipamorelin
The clinic advertises a combined growth-hormone-signaling protocol after baseline evaluation.
Provider source ↗04
2Provider-advertised metabolic compounds
Ipamorelin with tesamorelin
This provider-named combination appears in the current catalog; regulatory status and availability require direct confirmation.
Provider source ↗AOD-9604, 5-amino-1-MQ, and SLU-PP-332
The provider advertises these metabolic compounds; this listing does not characterize them as approved or lawfully available.
Provider source ↗05
1Hormone health
TRT and hormone-restoration programs
Men's testosterone and women's hormone-restoration services are listed in the current precision-medicine catalog.
Provider source ↗06
1Medical weight management
Metabolic and weight-management care
The clinic advertises GLP-1 and other provider-selected metabolic pathways within its biomarker-led model.
Provider source ↗07
1Laboratory services
Deep-dive biomarker testing
The practice advertises broad baseline panels and repeat data review to guide and adjust protocols.
Provider source ↗08
1Performance testing
PNOĒ metabolic testing
Respiratory and metabolic performance testing appears in the current clinic service catalog.
Provider source ↗09
1Infusion and recovery services
IV therapy and recovery services
IV therapy and in-clinic recovery services are listed alongside the precision-medicine programs.
Provider source ↗Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.
Coverage and research
Explore this provider’s markets
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Related provider profiles
Evidence
Sources reviewed
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
- 1BIOGENEX — Official Website ↗
Supports: identity location care model and service catalog · Checked Jul 29, 2026
- 2BIOGENEX — About ↗
Supports: current clinicians · Checked Jul 29, 2026
- 3BIOGENEX — Contact ↗
Supports: address phone connecticut telehealth and eligibility limit · Checked Jul 29, 2026
- 4BIOGENEX — Peptide Therapy ↗
Supports: peptide formulary baseline process and reassessment · Checked Jul 29, 2026